Metabolism and Pharmacokinetic Study of Ardipusilloside I in Rats

Abstract

Ardipusilloside I, extracted from Ardisia pusilla A.DC, effectively inhibits the progression of several cancers in animal models and is a potential anti-cancer drug candidate. However, the metabolism and pharmacokinetic characteristics of ardipusilloside I remain unknown. In this study, we developed a highly sensitive liquid chromatography-tandem MS method to determine the ardipusilloside I concentration in rat plasma using ginsenoside Re (whose structure is similar to ardipusilloside I) as the internal standard. After oral administration of ardipusilloside I, its four possible metabolites (M1, M2, M3, and M4, whose structures were determined by MS) were detected in the content from rat small intestine. In rat plasma, however, only M3 and M4 were detected after oral administration of ardipusilloside I. None of the metabolites were detected in plasma samples after intravenous administration of ardipusilloside I to rats. These results indicated that the metabolites, but not the drug itself, were absorbed into plasma after oral administration of ardipusilloside I to rats and that M3 and M4 may be responsible for the antitumor activity of orally administered ardipusilloside I in rat models of cancer.

Key words

ardipusilloside I–LC-MS/MS - pharmacokinetic - Ardisia pusilla - Myrsinaceae

References

• 1 Tao X J, Wang P X, Yang X J, Yao H, Liu J, Cao Y X. Inhibitory effect of ardipusilloside-I on Lewis pulmonary carcinoma and hepatocarcinoma SMMC-7721.  Zhong Yao Cai. 2005;  28 574-577
• 2 Tao X J, Long J W, He J Y, Yao L P, Liu J, Cao Y X. Antitumor and immunological regulation effects of ardipusilloside-I.  Chin Pharmacol Bull. 2005;  21 1070-1073
• 3 Cao Y X, Zheng J P, Tao X J, Liu J, Long J W. Effect of ardipusilloside-I on immunological function in immunosuppressed mice induced by cyclophosphamide.  Chin Pharm J. 2005;  40 1553-1555
• 4 Zhang Y M, Qu Y L, Zhang J, Wang X J. Ardipusilloside I purified from Ardisia pusilla competitively binds VEGFR and induces apoptosisin NCI-H460 cells.  Phytomedicine. 2010;  17 519-526
• 5 Li J, Zhang L, Fei Z, Zhang X, Zhang X N, Zheng H N, Liang J W, Huo J L. Apoptosis of glioma SHG-44 cells induced by ardipusilloside and its mechanism.  Chin J Clin Neurosurg. 2009;  5 57-60
• 6 Sun L W, Wang X J, Song J N, Sun W J. ELSD-HPLC determination of ardipusilloside I in Ardisia pusilla A. DC.  Chin J Pharm Anal. 2008;  28 1845-1847
• 7 Kim M K, Lee T H, Suh J H, Eom H Y, Min J W, Yeom H, Kim U, Jung H J, Cha K H, Choi Y S, Youm J R, Han S B. Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of goserelin in rabbit plasma.  J Chromatogr B Analyt Technol Biomed Life Sci. 2010;  878 2235-2242
• 8 Giannetti L, Longo F, Buiarelli F, Russo M V, Neri B. Tetracycline residues in royal jelly and honey by liquid chromatography tandem mass spectrometry: validation study according to Commission Decision 2002/657/EC.  Anal Bioanal Chem. 2010;  398 1017-1023
• 9 Chen G T, Yang M, Guo D A. Metabolic study of ginsenoside Re in rats.  China J Chin Mater Med. 2009;  24 1540-1543
• 10 Qian T, Cai Z, Wong R N, Mak N K, Jiang Z H. In vivo rat metabolism and pharmacokinetic studies of ginsenoside Rg3.  J Chromatogr B Analyt Technol Biomed Life Sci. 2005;  816 223-232
• 11 Qian T, Cai Z. Biotransformation of ginsenosides Rb1, Rg3 and Rh2 in rat gastrointestinal tracts.  Chin Med. 2010;  5 19
• 12 Yang L, Xu S, Liu C, Su Z. In vivo metabolism study of ginsenoside Re in rat using high-performance liquid chromatography coupled with tandem mass spectrometry.  Anal Bioanal Chem. 2009;  395 1441-1451
• 13 Joo K M, Lee J H, Jeon H Y, Park C W, Hong D K, Jeong H J, Lee S J, Lee S Y, Lim K M. Pharmacokinetic study of ginsenoside Re with pure ginsenoside Re and ginseng berry extracts in mouse using ultra performance liquid chromatography/mass spectrometric method.  J Pharm Biomed Anal. 2010;  51 278-283
• 14 Akao T, Hayashi T, Kobashi K, Kanaoka M, Kato H, Kobayashi M, Takeda S, Oyama T. Intestinal bacterial hydrolysis is indispensable to absorption of 18 beta-glycyrrhetic acid after oral administration of glycyrrhizin in rats.  J Pharm Pharmacol. 1994;  46 135-137
• 15 Akao T, Kida H, Kanaoka M, Hattori M, Kobashi K. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng.  J Pharm Pharmacol. 1998;  50 1155-1160
• 16 Akao T, Kanaoka M, Kobashi K. Appearance of compound K, a major metabolite of ginsenoside Rb1 by intestinal bacteria, in rat plasma after oral administration–measurement of compound K by enzyme immunoassay.  Biol Pharm Bull. 1998;  21 245-249
• 17 Bae E A, Han M J, Choo M K, Park S Y, Kim D H. Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities.  Biol Pharm Bull. 2002;  25 58-63